首页|武汉某医院重症监护室肺炎克雷伯菌感染及耐药性分析

武汉某医院重症监护室肺炎克雷伯菌感染及耐药性分析

扫码查看
目的 分析2017年1月至2021年12月肺炎克雷伯菌在华中科技大学同济医学院附属协和医院重症监护室(ICU)的分布及耐药情况,为临床合理使用抗菌药物提供参考.方法 收集2017年1月至2021年12月华中科技大学同济医学院附属协和医院ICU送检的各类标本中分离到的肺炎克雷伯菌,共978株,对其进行药敏实验,回顾性分析其临床分布及耐药性.结果 近5年自本院ICU分离的肺炎克雷伯菌大部分来源于痰液标本,占73.42%.药敏结果显示,肺炎克雷伯菌对大多抗菌药物耐药率整体呈上升趋势,对头孢吡肟、头孢曲松、头孢呋辛、头孢他啶和头孢哌酮/舒巴坦的耐药率分别由62.96%、64.44%、66.67%、62.04%和53.27%上升至83.99%、85.10%、86.60%、80.90%和72.00%,上升明显.另外,分离的耐碳青霉烯类肺炎克雷伯菌占比高达66.77%.结论 我院ICU分离的肺炎克雷伯菌对抗菌药物的耐药率均高于2021年CHINET中国细菌耐药监测结果中克雷伯菌属的耐药率,且耐碳青霉烯类肺炎克雷伯菌分离率高.我院应加强对病原菌的耐药性检测,指导临床医生合理使用抗菌药物,控制耐药感染菌株在医院的流行.同时加强对ICU工作人员的医院感染控制的培训.
Analysis of Infection and Drug Resistance of Klebsiella pneumoniae in the ICU of a Hospital in Wuhan
Objective To analyze the distribution and drug resistance of Klebsiella pneumoniae isolated from the Intensive Care Unit(ICU)of Union Hospital,Tongji Medical College,Huazhong University of Science and Technology from January 2017 to December 2021,so as to provide the reference for clinical rational use of antibiotics.Methods Between January 2017 and December 2021,a total of 978 Klebsiella pneumoniae strains were isolated from different specimens in the intensive care unit of Union Hospital,Tongji Medical College,Huazhong University of Science and Technology.The clinical distribution and drug resistance were retrospectively analyzed.Results The majority of Klebsiella pneumoniae isolated from the ICU of our hospital in the last 5 years was from sputum samples,accounting for 73.42%.Drug sensitivity results showed that the resistance rate of Klebsiella pneumoniae to most antibiotics showed an overall increasing trend.The resistance rates to cefepime,ceftriaxone,cefuroxime,ceftazidime and cefoperazone/sulbactam increased from 62.96%,64.44%,66.67%,62.04%and 53.27%to 83.99%,85.10%,86.60%,80.90%and 72.00%,respectively.In addition,carbapenem-resistant Klebsiella pneumoniae accounted for 66.77%.Conclusions Compared to Klebsiella pneumoniae in CHINET in 2021,the drug resistance rate of Klebsiella pneumoniae isolated from our hospital's intensive care unit to antibiotics was greater,and there was a high isolation rate of carbapenem-resistant Klebsiella pneumoniae.The hospital should strengthen the detection of drug resistance to pathogens,guide clinicians to use rationally and control the prevalence of drug-resistant strains in the hospital.Meanwhile,ICU medical should be trained in nosocomial infection control.

Klebsiella pneumoniaecarbapenem-resistant Klebsiella pneumoniaedrug sensitivity testantibioticsdrug resistanceantimicrobial resistance surveillance

袁思琪、李冰一、刘施函、杜帅先

展开 >

华中科技大学同济医学院附属协和医院检验科,武汉 430022

肺炎克雷伯菌 耐碳青霉烯类肺炎克雷伯菌 药敏试验 抗菌药物 耐药性 耐药监测

2024

国外医药(抗生素分册)
中国医药集团总公司四川抗菌素工业研究所,中国医学科学院医药生物技术研究所

国外医药(抗生素分册)

影响因子:0.852
ISSN:1001-8751
年,卷(期):2024.45(2)
  • 22